Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,942,011
-$9,124,605 QoQ
Shares Held
136,625
-53.5% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#88
of 329 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Derivatives in PCVX
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$1,014,312
PutShares
31,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,705,485 across 322 Biotechnology names. PCVX ranks #132 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in PCVX
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,942,011 | 136,625 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $17,066,616 | 293,695 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,576,925 | 424,294 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $34,181,791 | 948,967 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,014,312 | 31,200 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $35,918,315 | 1,104,839 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,132,800 | 30,000 | Put | Sole | 2025-05-15 | |
| 2025-03-31 | $1,925,760 | 51,000 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $15,611,079 | 413,429 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $22,640,675 | 276,578 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $34,102,167 | 298,435 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $15,383,727 | 203,731 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $14,138,940 | 206,982 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $43,421,929 | 691,432 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $29,714,661 | 582,869 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $60,630,755 | 1,214,072 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $499,400 | 10,000 | Put | Sole | 2023-08-14 | |
| 2023-03-31 | $49,235,302 | 1,313,642 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $58,474,593 | 1,219,491 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $18,871,728 | 786,322 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,318,684 | 566,116 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,344,688 | 262,720 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,811,624 | 286,323 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,136,175 | 281,284 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,104,448 | 315,613 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,980,716 | 353,454 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $11,314,143 | 425,824 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,723,690 | 95,660 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $27,447,531 | 868,318 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||